An exploratory analysis of tamsulosin for Overactive Bladder (OAB) in men with varying voiding symptom burden.
To evaluate tamsulosin (α-blocker therapy) for male overactive bladder (OAB) and to examine if indicators of concomitant benign prostatic hyperplasia (BPH) are associated with OAB symptom improvement.